Cost-effectiveness of HLA-B*15:02 screening in Malaysia
Br J Dermatol
.
2017 Oct;177(4):904-905.
doi: 10.1111/bjd.15832.
Authors
C Plumpton
1
,
D Hughes
1
Affiliation
1
Centre for Health Economics and Medicines Evaluation, Bangor University, Bangor, Wales, U.K.
PMID:
29052888
DOI:
10.1111/bjd.15832
No abstract available
Publication types
Comment
MeSH terms
Cost-Benefit Analysis*
HLA-B Antigens*
Humans
Malaysia
Substances
HLA-B Antigens